Olema Pharmaceuticals, Inc. (OLMA) Misses Q2 EPS by 6c

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q2 EPS of ($0.61), $0.06 worse than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.

You May Also Be Interested In

• Calumet Specialty Products Partners (CLMT) PT Raised to $47 at UBS
• Trump: All Mines Have Been Removed Or Detonated From Hormuz
• Synopsys (SNPS) call put ratio 1 call to 2 puts into quarter results